X-71397593-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_004606.5(TAF1):c.3620+127A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.98 ( 37078 hom., 31281 hem., cov: 22)
Exomes 𝑓: 0.97 ( 240259 hom. 190481 hem. )
Failed GnomAD Quality Control
Consequence
TAF1
NM_004606.5 intron
NM_004606.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.410
Publications
1 publications found
Genes affected
TAF1 (HGNC:11535): (TATA-box binding protein associated factor 1) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is the basal transcription factor TFIID, which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes the largest subunit of TFIID. This subunit binds to core promoter sequences encompassing the transcription start site. It also binds to activators and other transcriptional regulators, and these interactions affect the rate of transcription initiation. This subunit contains two independent protein kinase domains at the N- and C-terminals, but also possesses acetyltransferase activity and can act as a ubiquitin-activating/conjugating enzyme. Mutations in this gene result in Dystonia 3, torsion, X-linked, a dystonia-parkinsonism disorder. Alternative splicing of this gene results in multiple transcript variants. This gene is part of a complex transcription unit (TAF1/DYT3), wherein some transcript variants share exons with TAF1 as well as additional downstream DYT3 exons. [provided by RefSeq, Oct 2013]
TAF1 Gene-Disease associations (from GenCC):
- intellectual disability, X-linked, syndromic 33Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
- X-linked dystonia-parkinsonismInheritance: XL, Unknown Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
- X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.03).
BP6
Variant X-71397593-A-G is Benign according to our data. Variant chrX-71397593-A-G is described in ClinVar as Benign. ClinVar VariationId is 1278289.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004606.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TAF1 | NM_004606.5 | MANE Select | c.3620+127A>G | intron | N/A | NP_004597.3 | |||
| TAF1 | NM_001286074.2 | c.3620+127A>G | intron | N/A | NP_001273003.2 | ||||
| TAF1 | NM_001440852.1 | c.3620+127A>G | intron | N/A | NP_001427781.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TAF1 | ENST00000423759.6 | TSL:5 MANE Select | c.3620+127A>G | intron | N/A | ENSP00000406549.2 | |||
| TAF1 | ENST00000373790.9 | TSL:1 | c.3557+127A>G | intron | N/A | ENSP00000362895.5 | |||
| TAF1 | ENST00000683782.1 | c.3620+127A>G | intron | N/A | ENSP00000506996.1 |
Frequencies
GnomAD3 genomes AF: 0.977 AC: 107172AN: 109690Hom.: 37081 Cov.: 22 show subpopulations
GnomAD3 genomes
AF:
AC:
107172
AN:
109690
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.973 AC: 685508AN: 704853Hom.: 240259 AF XY: 0.978 AC XY: 190481AN XY: 194821 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
685508
AN:
704853
Hom.:
AF XY:
AC XY:
190481
AN XY:
194821
show subpopulations
African (AFR)
AF:
AC:
17695
AN:
17781
American (AMR)
AF:
AC:
23001
AN:
23339
Ashkenazi Jewish (ASJ)
AF:
AC:
13427
AN:
13771
East Asian (EAS)
AF:
AC:
26250
AN:
26250
South Asian (SAS)
AF:
AC:
37225
AN:
37650
European-Finnish (FIN)
AF:
AC:
35705
AN:
36456
Middle Eastern (MID)
AF:
AC:
3047
AN:
3148
European-Non Finnish (NFE)
AF:
AC:
497657
AN:
514063
Other (OTH)
AF:
AC:
31501
AN:
32395
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
735
1470
2206
2941
3676
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10352
20704
31056
41408
51760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.977 AC: 107227AN: 109743Hom.: 37078 Cov.: 22 AF XY: 0.979 AC XY: 31281AN XY: 31957 show subpopulations
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
107227
AN:
109743
Hom.:
Cov.:
22
AF XY:
AC XY:
31281
AN XY:
31957
show subpopulations
African (AFR)
AF:
AC:
29966
AN:
30110
American (AMR)
AF:
AC:
9857
AN:
10171
Ashkenazi Jewish (ASJ)
AF:
AC:
2573
AN:
2634
East Asian (EAS)
AF:
AC:
3501
AN:
3503
South Asian (SAS)
AF:
AC:
2476
AN:
2505
European-Finnish (FIN)
AF:
AC:
5587
AN:
5701
Middle Eastern (MID)
AF:
AC:
205
AN:
215
European-Non Finnish (NFE)
AF:
AC:
50939
AN:
52737
Other (OTH)
AF:
AC:
1446
AN:
1490
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
95
190
285
380
475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
828
1656
2484
3312
4140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.